Page last updated: 2024-11-03

risperidone and Dissociative Identity Disorder

risperidone has been researched along with Dissociative Identity Disorder in 2 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Dissociative Identity Disorder: A dissociative disorder in which the individual adopts two or more distinct personalities. Each personality is a fully integrated and complex unit with memories, behavior patterns and social friendships. Transition from one personality to another is sudden.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Urbina, TM1
May, T1
Hastings, M1
Lai, CH1

Other Studies

2 other studies available for risperidone and Dissociative Identity Disorder

ArticleYear
Navigating Undiagnosed Dissociative Identity Disorder in the Inpatient Setting: A Case Report.
    Journal of the American Psychiatric Nurses Association, 2017, Volume: 23, Issue:3

    Topics: Adaptation, Psychological; Adult; Antidepressive Agents; Antipsychotic Agents; Cognitive Behavioral

2017
Dissociative identity disorder may be relieved by the combined treatments of mirtazapine and risperidone: case report of an adolescent.
    The Journal of neuropsychiatry and clinical neurosciences, 2012,Spring, Volume: 24, Issue:2

    Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Dissociative Identity Disorder;

2012